Sun Pharma does it again! - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Sun Pharma does it again!

Apr 19, 2001

Sun Pharma has done it again. Mainly on the back of a better product mix, the company reported an increase in net profit of 49.2% against less than proportionate growth in topline. This numbers exclude the merger with Pradeep Drug Company Ltd and also Sun Pharmaceutical Advanced Research Centre Ltd, which is the research arm of the company.

(Rs m) FY00 FY01 Change
Sales 4,785.5 6,132.3 28.1%
Other Income 36.3 67.4 85.7%
Expenditure 3,717.5 4,625.1 24.4%
Operating Profit (EBDIT) 1,068.0 1,507.2 41.1%
Operating Profit Margin (%) 22.3% 24.6%
Interest 14.4 (20.9) -245.1%
Depreciation 126.9 151.6 19.5%
Profit before Tax 963.0 1,443.9 49.9%
Other Adjustments -
Tax 58.7 94.7 61.3%
Profit after Tax/(Loss) 904.3 1,349.2 49.2%
Net profit margin (%) 18.9% 0.2
No. of Shares (eoy) (m) 15.4 46.8
Diluted Earnings per share 19.3 28.9
P/E 18.3

The Company's focus on high margin theraputic segments seems to be paying off as is evident from considerable improvement in operating margins. The operating margins have shown an improvement of more than 200 basis points.

At Rs 528 the comapany trades on a multiple of 18.3x FY01 earnings. The three year average P/E for the company is 23.8x.

Equitymaster requests your view! Post a comment on "Sun Pharma does it again!". Click here!


More Views on News

SUN PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 22, 2021 | Updated on Oct 22, 2021

Here's an analysis of the annual report of SUN PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

Sun Pharma Zooms 10% as June Quarter Earnings Beat Estimates (Views On News)

Jul 30, 2021

Here's a rundown on Sun Pharma's June quarter results.

Sun Pharma's Stock Falls 4% After Its March Quarter Results (Views On News)

May 28, 2021

In the past three months, the stock has outperformed the market by gaining nearly 20%. Can it go higher?

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

Don't Sell these Stocks if the Market Falls (Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

How to Find Your Next 10-Bagger in this Market (Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

6 Popular Stocks that Turned into Penny Stocks (Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.


Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


Nov 30, 2021 (Close)


  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks